Lucira Health Inc
LHDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.36M
Close$
Share Statistics
| Market cap | $18.36 Million |
|---|---|
| Enterprise Value | $26.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.86 |
| Beta | 3.76 |
| Outstanding Shares | 40,216,244 |
Return
| Return on Equity | -234.86% |
|---|---|
| Return on Assets | -75.59% |
| Return on Invested Capital | -132.82% |
Valuation & Multiples
| P/E Ratio | -0.24 |
|---|---|
| PEG | -0.07 |
| Price to Sales | 0.09 |
| Price to Book Ratio | 0.45 |
| Enterprise Value to Revenue | 0.13 |
| Enterprise Value to EBIT | -0.19 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.8 |
| Debt to Equity | 0.79 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lucira Health Inc
57 employeesLucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-...